Erratum to Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults

被引：0
|
作者：
M. Sanford
机构：
来源：
Drugs | 2012年 / 72卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2176 / 2176
相关论文
共 50 条
  • [31] 13-valent pneumococcal conjugate vaccine (PCV13)
    Jefferies, Johanna M. C.
    Macdonald, Emily
    Faust, Saul N.
    Clarke, Stuart C.
    HUMAN VACCINES, 2011, 7 (10): : 1012 - 1018
  • [32] Recent Advances in Pneumococcal Conjugate Vaccines: A 13-Valent Pneumococcal Conjugate Vaccine
    Ceyhan, Mehmet
    JOURNAL OF PEDIATRIC INFECTION, 2011, 5 (02): : 68 - 73
  • [33] Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
    Sucher, Allana J.
    Chahine, Elias B.
    Nelson, Michael
    Sucher, Brandon J.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1516 - 1524
  • [34] Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults
    Gaillat, J.
    MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (06): : 215 - 221
  • [35] Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults
    Scott, Daniel
    Ruckle, Jon
    Dar, Marilyn
    Baker, Sherryl
    Kondoh, Hiroaki
    Lockhart, Stephen
    PEDIATRICS INTERNATIONAL, 2008, 50 (03) : 295 - 299
  • [36] Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults
    Scott, Daniel A.
    Komjathy, Steven F.
    Hu, Branda T.
    Baker, Sherryl
    Supan, Lois A.
    Monahan, Carol A.
    Gruber, William
    Siber, George R.
    Lockhart, Stephen P.
    VACCINE, 2007, 25 (33) : 6164 - 6166
  • [37] COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS IN PORTUGAL
    Alarcao, J.
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [38] Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
    Jackson, Lisa A.
    Gurtman, Alejandra
    van Cleeff, Martin
    Frenck, Robert W.
    Treanor, John
    Jansen, Kathrin U.
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    VACCINE, 2013, 31 (35) : 3594 - 3602
  • [39] The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults
    Frenck, Robert W., Jr.
    Yeh, Sylvia
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (01) : 63 - 77
  • [40] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices
    Kaye, Donald
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (01)
12345